Torrent Pharmaceuticals (TORNTPHARM) — Announcement

Torrent Pharmaceuticals disclosed a change in shareholding structure under SEBI Takeover Regulations filed on April 8, 2025. The announcement involves modifications to promoter or significant shareholder positions, triggering mandatory disclosure requirements. Details specify the nature and extent of shareholding changes, though specific percentage shifts or transaction amounts require review of the complete filing documentation for precise investor impact assessment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this announcement affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 8 April 2025?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 8 April 2025

MUTHOOTFIN Muthoot Finance Limited Corporate Action ICICIPRULI ICICI Prudential Life Insurance Company Limited Corporate Action OBEROIRLTY Oberoi Realty Limited Announcement SUNPHARMA Sun Pharmaceutical Industries Limited Announcement IDEA Vodafone Idea Limited Corporate Action AXISBANK Axis Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.